Contributor(s)Rosolowski, Tacey Ann
KeywordsB: MD Anderson Culture; C: Dedication to MD Anderson, to Patients, to Faculty/Staff; B: The MD Anderson Brand, Reputation; C: Personal Reflections, Memories of MD Anderson; C: Leadership; D: On Leadership; C: This is MD Anderson; A: Personal Background;
B: Institutional Mission and Values; B: The University of Texas MD Anderson Cancer Center;
Full recordShow full item record
AbstractMs. Sollenberger provides her perspective on MD Anderson now, after serving at other institutions for many years. [pause in the recording] Ms. Sollenberger observes that MD Anderson is about all the people who are devoted, caring, compassionate and emotionally and professionally invested in patients and their families. In the last minutes of the interview, Ms. Sollenberger comments on how political issues can arise with leadership changes: these must settle down so the institution is not demoralized. Ms. Sollenberger talks about the importance of communication in healthcare, especially one-on-one communication. In closing, Ms. Sollenberger describes MD Anderson as a wonderful, essential organization for the U.S. and for Texas.
DateSeptember 27, 2013
Copyright/LicenseParts of this interview have been redacted. See Archivist for more information.
Showing items related by title, author, creator and subject.
the source. Gravity, Productivity and the Pattern of Production and TradeThe Pennsylvania State University CiteSeerX Archives; James E. Anderson; James E. Anderson; James E. Anderson (2016-09-23)I am grateful to Christian Broda for helpful comments on the first version of this paper at the NBER
Xylitol for the prevention of acute otitis media episodes in children aged 2-4 years: Protocol for a pragmatic randomised controlled trialPersaud, N; Laupacis, A; Azarpazhooh, A; Birken, C; Hoch, JS; Isaranuwatchai, W; Maguire, JL; Mamdani, MM; Thorpe, K; Allen, C; et al. (eScholarship, University of California, 2018-08-01)© 2018 Author(s) (or their employer(s)). Introduction Xylitol (or 'birch sugar') is a naturally occurring sugar with antibacterial properties that has been used as a natural non-sugar sweetener in chewing gums, confectionery, toothpaste and medicines. In this preventative randomised trial, xylitol will be tested for the prevention of acute otitis media (AOM), a common and costly condition in young children. The primary outcome will be the incidence of AOM. Secondary outcomes will include upper respiratory tract infections (URTIs) and dental caries. Methods and analysis This study will be a pragmatic, blinded (participant and parents, practitioners and analyst), two-armed superiority, placebo-controlled randomised trial with 1:1 allocation, stratified by clinical site. The trial will be conducted in the 11 primary care group practices participating in the TARGet Kids! research network in Canada. Eligible participants between the ages of 2-4 years will be randomly assigned to the intervention arm of regular xylitol syrup use or the control arm of regular sorbitol use for 6 months. We expect to recruit 236 participants, per treatment arm, to detect a 20% relative risk reduction in AOM episodes. AOM will be identified through chart review. The secondary outcomes of URTIs and dental caries will be identified through monthly phone calls with specified questions. Ethics and dissemination Ethics approval from the Research Ethics Boards at the Hospital for Sick Children and St. Michael's Hospital has been obtained for this study and also for the TARGet Kids! research network. Results will be submitted for publication to a peer-reviewed journal and will be discussed with decision makers.